TickerFacts.

Company research / ILMN

Illumina, Inc. (ILMN)

Build a valuation ↗↓ Download CSV

SEC name ILLUMINA, INC. · CIK 0001110803 · Nasdaq · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends around Jan 3

For the year ended 2025-12-28, Illumina, Inc. reported revenue of $4.34B. Revenue fell 0.7% from the prior annual period. Over the twelve months to 2026-06-28, revenue was $4.49B.

Key ratios (year ended 2025-12-28)

66.1%
Gross margin
18.6%
Operating margin
19.6%
Net margin
31.2%
Return on year-end equity
-0.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-13

Headquarters locality: San Diego · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-28 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-28		2025-12-282024-12-292023-12-312023-01-01, Fiscal 20222022-01-02, Fiscal 20212021-01-03, Fiscal 20202019-12-292018-12-302017-12-312017-01-01, Fiscal 2016
Revenue$4.49B$4.34B$4.37B$4.50B$4.58B$4.53B$3.24B$3.54B$3.33B$2.75B$2.40B
Cost of Revenue$1.51B$1.47B$1.51B$1.76B$1.61B$1.37B$1.04B$1.08B$1.03B$926.00M$732.00M
Gross Profit$2.98B$2.87B$2.86B$2.74B$2.97B$3.15B$2.20B$2.47B$2.30B$1.83B$1.67B
R&D Expense$960.00M$967.00M$1.17B$1.35B$1.32B$1.19B$682.00M$647.00M$623.00M$546.00M$504.00M
Operating Income$883.00M$807.00M-$833.00M-$1.07B-$4.18B-$123.00M$580.00M$985.00M$883.00M$606.00M$587.00M
Depreciation & Amortizationn/a$270.00M$354.00M$432.00M$394.00M$251.00M$187.00M$188.00M$179.00M$156.00M$141.00M
EBITDAn/a$1.08B-$479.00M-$637.00M-$3.79B$128.00M$767.00M$1.17B$1.06B$762.00M$728.00M
Net Income$824.00M$850.00M-$1.22B-$1.16B-$4.40B$762.00M$656.00M$1.00B$826.00M$726.00M$463.00M
EPS (Diluted)n/a$5.45-$7.69-$7.34-$28.00$5.04$4.45$6.74$5.56$4.92$3.07
Total Assets$6.65B$6.64B$6.30B$10.11B$12.25B$15.22B$7.58B$7.32B$6.96B$5.26B$4.28B
Shareholders' Equity$2.84B$2.72B$2.37B$5.75B$6.60B$10.74B$4.69B$4.61B$3.76B$2.75B$2.20B
Cash & Equivalentsn/an/an/an/an/an/an/an/a$1.14B$1.23B$735.00M
Operating Cash Flow$1.09B$1.08B$837.00M$478.00M$392.00M$545.00M$1.08B$1.05B$1.14B$875.00M$779.00M
Capital Expenditures$164.00M$148.00M$128.00M$195.00M$286.00M$208.00M$189.00M$209.00M$296.00M$310.00M$260.00M
Free Cash Flow$931.00M$931.00M$709.00M$283.00M$106.00M$337.00M$891.00M$842.00M$846.00M$565.00M$519.00M
Share Repurchases$542.00M$742.00M$116.00M$0$0$0$736.00M$324.00M$201.00M$251.00M$249.00M
Shares Outstandingn/a153.00M159.00M159.00M158.00M157.00M146.00M147.00M147.00M147.00M146.00M
Weighted Average Diluted Sharesn/a156.00M159.00M158.00M157.00M151.00M148.00M149.00M149.00M148.00M148.00M
EPS (Basic)n/a$5.47-$7.69-$7.34-$28.00$5.07$4.48$6.81$5.63$4.96$3.09

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView